Vedolizumab in combined immune checkpoint therapy-induced infliximab-refractory colitis in a patient with metastatic melanoma: A case report.

Randhawa, Manreet; Gaughran, Gregory; Archer, Christine; Pavli, Paul; Morey, Adrienne; Ali, Sayed; Yip, Desmond.

Randhawa M; Department of Medical Oncology, Canberra Region Cancer Centre, The Canberra Hospital, Canberra, ACT 2605, Australia.
Gaughran G; Department of Medical Oncology, Canberra Region Cancer Centre, The Canberra Hospital, Canberra, ACT 2605, Australia.
Archer C; Department of Medical Oncology, Canberra Region Cancer Centre, The Canberra Hospital, Canberra, ACT 2605, Australia.
Pavli P; Department of Gastroenterology, The Canberra Hospital, Canberra, ACT 2605, Australia.
Morey A; Department of Anatomical Pathology, The Canberra Hospital, Canberra, ACT 2605, Australia.
Ali S; Department of Medical Oncology, Canberra Region Cancer Centre, The Canberra Hospital, Canberra, ACT 2605, Australia.
Yip D; Department of Medical Oncology, Canberra Region Cancer Centre, The Canberra Hospital, Canberra, ACT 2605, Australia.

World J Clin Oncol ; 10(10): 350-357, 2019 Oct 24.

Article en En | MEDLINE | ID: mdl-31799150